Astrocytoma and glioblastoma are fast-growing brain cancers that often return after surgery, with survival for astrocytoma patients averaging only four to five months. While medications
Lynk Pharmaceuticals announced a significant development in its pipeline with the China National Medical Products Administration (NMPA) formally accepting the New Drug Application (NDA) for
I’ve always been a nature lover. I like nothing better than going for a hike in the woods or strolling along the beach or gazing
Editor’s Note: Patient Worthy is honored to share this submission by Regina Portnoy, a clinical researcher with 20 years of experience working alongside patients. Many
Daiichi Sankyo and Merck announced a significant regulatory milestone with the FDA’s acceptance and Priority Review of ifinatamab deruxtecan (I-DXd), a potentially first-in-class therapeutic targeting
As reported on BioPharmaDive, Roche is restarting efforts to get Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), approved in Europe by launching a
I’ve always been an overachiever – someone who puts their mind to something and delivers more than was expected, someone who strives for greatness. I
IDEAYA Biosciences and Servier announced promising Phase 2/3 trial results for darovasertib, a selective PKC inhibitor, combined with crizotinib in the treatment of metastatic uveal
As reported on Healthline, a man in Norway has entered sustained HIV remission following a stem cell transplant, becoming one of a small number of
Two University of Michigan professors, Jolanta Grembecka and her husband Tomasz Cierpicki, created the newly approved leukemia drug ziftomenib. Its recent FDA approval offers new
Sarepta Therapeutics has announced a significant regulatory milestone in its efforts to secure permanent FDA approval for two breakthrough Duchenne muscular dystrophy (DMD) treatments. As
Editor’s Note: Patient Worthy is honored to share this article, originally submitted by Camille Johnson. For chronic disease patients living with rare conditions and long-term
As reported on Cardiovascular Business, new long-term findings presented at the American College of Cardiology (ACC) 2026 meeting provide compelling evidence that early and continuous
A pivotal study recently published in the journal Gero Science has revealed new insights into how individual brain regions age and why some are more
A decade of accumulated clinical experience with nusinersen has culminated in a significant regulatory advancement. According to Pharma Times Online, Biogen’s newly approved high-dose Spinraza
As reported by Manila Times, Ocular Therapeutix has released additional one‑year results from its Phase 3 SOL‑1 trial evaluating AXPAXLI (formerly OTX‑TKI) for the treatment
As reported on BioPharmaDive, several biopharmaceutical companies reported notable clinical and regulatory developments this week, with investor response reflecting growing confidence in both late‑stage pipelines
Researchers have demonstrated substantial therapeutic benefits for brepocitinib, an oral tyrosine kinase 2/Janus kinase 1 inhibitor, in adults with dermatomyositis, according to findings from a
“In January 2023, I encountered a significant challenge when I was diagnosed with male breast cancer. Instead of celebrating Valentine's Day with flowers and a romantic dinner for my fiancée, I found myself heading to the hospital for a double mastectomy.
Getting through this was not easy. I struggled with feelings of depression, despair, and a sense of being lost and unfocused. I felt truly defeated.
But then I realized something important that men need to know two things. First, that they too can develop breast cancer; it's not solely a woman's disease. Second, there is still life to be lived after cancer.
In that moment, I discovered my purpose."
For thirty years, Vic has been traveling around North America speaking on such topics as communication, leadership, and how to cook the perfect steak. He approaches each audience with the goal of finding the fun in everything we do, giving them tips, tricks, and techniques, whether it's at a leadership symposium or in a cooking class. As an award-winning writer, Vic's first published article was in 1990, and he has been going strong ever since. Dovetailing into his speaking career, Vic believes every word carries weight and has purpose. His articles on leadership, motivation, and cooking appear in journals around the country every month.
If you are interested in sharing your healthcare journey, click the link: bit.ly/4dV7gru
#malebreastcancer #shareyourstory #patientworthy #whatnext #breastcancer #breastcancerjourney
Living with lupus means paying attention to more than what can be seen on the surface. Kidney involvement may develop gradually, making regular testing and early detection an important part of protecting long-term health. Understanding how lupus nephritis is identified can help encourage proactive care, informed conversations, and earlier intervention when it matters most. 💜
#lupusnephritis #lupusawareness
💚 National Children’s Mental Health Awareness Day 💚
Mental health challenges affect millions of children, and early support can change lives. When kids get the care they need, they’re more likely to succeed in school, relationships, and life.
Let’s work together to:
🧠 Normalize mental health conversations
🏫 Support schools and families
🤍 Ensure no child feels alone
Because caring for kids means caring for their mental health.
#ChildrensMentalHealthAwarenessDay #MentalHealthAdvocacy #PatientWorthy #OpenConversation
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
